We found resources matching your search…

Sort by
Professional Investors
Where are the opportunities amidst slowing global growth?
Where are the opportunities amidst slowing global growth?
US growth is slowing, but recovery elsewhere is picking up pace.
Professional Investors
Reforms rejuvenate South Africa and South Korea
Reforms rejuvenate South Africa and South Korea
Changes in government and corporate governance are boosting investor confidence.
Visit arrow right black
Professional Investors
How did tariffs transform the ETF landscape?
How did tariffs transform the ETF landscape?
Investors are rethinking their ETF strategies in response to market shifts.
Professional Investors
Structural shifts boost EM debt
Structural shifts boost EM debt
Emerging market debt has demonstrated resilience amid market turbulence.
Visit arrow right black
Professional Investors
AI, uncertainty, and opportunity ahead of 2026
AI, uncertainty, and opportunity ahead of 2026
Investors face volatility, but innovation and Europe’s growth potential offer support.
Professional Investors
The 60/40 debate: Is it still relevant?
The 60/40 debate: Is it still relevant?
Equity-bond diversification is still a strong strategy for investors.
Visit arrow right black
Professional Investors
Forecasts are not foolproof
Forecasts are not foolproof
Could value investing help soften the blow of missed expectations?
Visit arrow right black
Professional Investors
T. Rowe Price Webinar - Ahead of the Curve: Impact of high sovereign debt on bond markets
How do bond markets shape strategies and create opportunities?
Visit arrow right black
Professional Investors
IHT reforms reshape inheritance planning
IHT reforms reshape inheritance planning
How can intergenerational wealth be managed effectively?
Visit arrow right black
Professional Investors
Active advantage on short-term opportunities
Active advantage on short-term opportunities
Is flexibility the key to strong returns?
Visit arrow right black
Professional Investors
A dose of clarity for pharma investors
A dose of clarity for pharma investors
European pharmaceuticals have dodged steep tariff threats.
Visit arrow right black
Professional Investors
Active approaches unlock bond returns
Active approaches unlock bond returns
Can active strategies uncover hidden value and boost returns?
Visit arrow right black
Not a member yet?
Get access to all of the Investment IQ curated content completely free today
IQ logo